BLOG

Natural Killer Cells Plus Immunotherapy for Triple-Negative Breast Cancer

Q: Your experimental protocol was given as third-line treatment, is that correct? Most patients were on their third line of treatment, but inclusion criteria were beyond first-line standard of care.